Cargando…
P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430959/ http://dx.doi.org/10.1097/01.HS9.0000971284.68877.ca |
| _version_ | 1785091084711362560 |
|---|---|
| author | Shadman, Mazyar Yeung, Cecilia Redman, Mary W Yun Lee, Sang Hoon Lee, Dong Ra, Susan Qian, David H Dezube, Bruce Chapuis, Aude Green, Damian Cowan, Andrew Cassaday, Ryan Kiem, Hans-Peter Warren, Houston E Milano, Filippo Gauthier, Jordan Hirayama, Alexandre Kwok, Mary Ujjani, Chaitra Maloney, David Gopal, Ajay Till, Brian |
| author_facet | Shadman, Mazyar Yeung, Cecilia Redman, Mary W Yun Lee, Sang Hoon Lee, Dong Ra, Susan Qian, David H Dezube, Bruce Chapuis, Aude Green, Damian Cowan, Andrew Cassaday, Ryan Kiem, Hans-Peter Warren, Houston E Milano, Filippo Gauthier, Jordan Hirayama, Alexandre Kwok, Mary Ujjani, Chaitra Maloney, David Gopal, Ajay Till, Brian |
| author_sort | Shadman, Mazyar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430959 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309592023-08-17 P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY Shadman, Mazyar Yeung, Cecilia Redman, Mary W Yun Lee, Sang Hoon Lee, Dong Ra, Susan Qian, David H Dezube, Bruce Chapuis, Aude Green, Damian Cowan, Andrew Cassaday, Ryan Kiem, Hans-Peter Warren, Houston E Milano, Filippo Gauthier, Jordan Hirayama, Alexandre Kwok, Mary Ujjani, Chaitra Maloney, David Gopal, Ajay Till, Brian Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430959/ http://dx.doi.org/10.1097/01.HS9.0000971284.68877.ca Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Shadman, Mazyar Yeung, Cecilia Redman, Mary W Yun Lee, Sang Hoon Lee, Dong Ra, Susan Qian, David H Dezube, Bruce Chapuis, Aude Green, Damian Cowan, Andrew Cassaday, Ryan Kiem, Hans-Peter Warren, Houston E Milano, Filippo Gauthier, Jordan Hirayama, Alexandre Kwok, Mary Ujjani, Chaitra Maloney, David Gopal, Ajay Till, Brian P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY |
| title | P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY |
| title_full | P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY |
| title_fullStr | P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY |
| title_full_unstemmed | P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY |
| title_short | P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY |
| title_sort | p1097: cd20 car-t therapy with mb-106 for btk inhibitor-refractory waldenström macroglobulinemia (wm)/ lymphoplasmacytic lymphoma (lpl) – single institution study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430959/ http://dx.doi.org/10.1097/01.HS9.0000971284.68877.ca |
| work_keys_str_mv | AT shadmanmazyar p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT yeungcecilia p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT redmanmaryw p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT yunleesang p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT hoonleedong p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT rasusan p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT qiandavidh p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT dezubebruce p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT chapuisaude p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT greendamian p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT cowanandrew p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT cassadayryan p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT kiemhanspeter p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT warrenhoustone p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT milanofilippo p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT gauthierjordan p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT hirayamaalexandre p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT kwokmary p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT ujjanichaitra p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT maloneydavid p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT gopalajay p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy AT tillbrian p1097cd20carttherapywithmb106forbtkinhibitorrefractorywaldenstrommacroglobulinemiawmlymphoplasmacyticlymphomalplsingleinstitutionstudy |